Table 5 Cardiovascular control markers in CEA and CAS patients evaluated in PRE, FU6 and FU12 during STAND.
STAND | CEA | CAS | ||||
|---|---|---|---|---|---|---|
PRE | FU6 | FU12 | PRE | FU6 | FU12 | |
µHP [ms] | 819.38 ± 100.85 | 899.09 ± 126.87§ | 845.95 ± 147.47 | 768.11 ± 132.42 | 821.81 ± 122.32* | 859.64 ± 108.29§ |
σ2HP [ms2] | 525.71 ± 500.51 | 773.58 ± 759.02 | 576.76 ± 624.09 | 257.66 ± 240.27 | 364.91 ± 414.46 | 549.17 ± 498.72 |
HFHP [ms2] | 105.46 ± 252.86 | 145.53 ± 273.7 | 133.84 ± 319.01 | 43.85 ± 42.64 | 97.74 ± 156.67 | 123.79 ± 172.56 |
LFHP/HFHP | 4.14 ± 7.02 | 2.33 ± 3.64 | 11.89 ± 55.83 | 1.34 ± 1.64 | 1.47 ± 3.64 | 0.80 ± 1.06 |
µSAP [mmHg] | 141.69 ± 26.04 | 148.14 ± 23.78 | 142.04 ± 29.72 | 143.24 ± 24.79 | 143.45 ± 30.9 | 146.85 ± 24.94 |
σ2SAP [mmHg2] | 33.56 ± 30.74 | 80.08 ± 234.09 | 33.21 ± 23.64 | 43.76 ± 29.06 | 30.23 ± 26.55 | 36.09 ± 32.72 |
LFSAP [mmHg2] | 5.34 ± 5.94 | 6.79 ± 7.51 | 4.83 ± 5.14 | 6.27 ± 7.19 | 4.52 ± 6.76 | 2.92 ± 2.43 |
αLF [ms/mmHg] | 9.69 ± 19.36 | 6.11 ± 7.16 | 7.13 ± 7.97 | 2.56 ± 1.91 | 3.64 ± 2.7 | 5.06 ± 4.25 |
αHF [ms/mmHg] | 3.97 ± 1.84 | 4.48 ± 2.58 | 4.64 ± 4.38 | 2.71 ± 1.71 | 6.19 ± 6.87§ | 4.32 ± 2.88 |
K2LF | 0.45 ± 0.23 | 0.37 ± 0.19 | 0.34 ± 0.19 | 0.31 ± 0.18* | 0.43 ± 0.23 | 0.28 ± 0.18# |
PhLF [rad] | -1.48 ± 0.84 | -1.22 ± 1.58 | -1.01 ± 1.67 | -0.83 ± 1.70 | -0.98 ± 1.46 | -1.35 ± 1.41 |
BRSLF [ms/mmHg] | 3.96 ± 4.54 | 3.37 ± 2.31 | 2.99 ± 2.36 | 1.64 ± 1.28* | 2.96 ± 2.61 | 3.00 ± 3.37 |
K2HF | 0.65 ± 0.23 | 0.58 ± 0.23 | 0.62 ± 0.23 | 0.63 ± 0.23 | 0.66 ± 0.23 | 0.57 ± 0.26 |
PhHF [rad] | -0.05 ± 1.21 | 0.27 ± 0.96 | 0.17 ± 1.24 | -0.11 ± 1.40 | 0.06 ± 1.23 | 0.35 ± 1.3 |
BRSHF [ms/mmHg] | 5.51 ± 10.45 | 4.38 ± 3.59 | 4.96 ± 5.6 | 2.42 ± 1.96 | 5.56 ± 5.00 | 5.40 ± 5.15 |